🔥🐔 BizChicken 🐔🔥
Companies Similar to Citius Pharmaceuticals, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Allarity Therapeutics, Inc.
Stenoparib, Dovitinib, IXEMPRA, Li Pla Cis, 2X-111
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing oncology therapeutics using companion diagnostics and drug response predictor technology.
Careers | Careers | Careers | About | About | About | About | About | About | About | About | Contact | Contact | Contact | Careers | About | About | About | About | About | About | About | About
Symbol: ALLR
Recent Price: $1.12
Industry: Biotechnology
CEO: Mr. Thomas H. Jensen
Sector: Healthcare
Employees: 5
Address: 210 Broadway, Cambridge, MA 02139
Phone: 401 426 4664
Last updated: 2024-12-31
Citius Pharmaceuticals, Inc.
Mino-Lok, Mino-Wrap, Halo-Lido, Nove Cite, I/ONTAK
Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of critical care products, including anti-infective products, adjunct cancer care, prescription products, and stem cell therapy.
About | Leadership | Directors | About | About | About | About | Contact | Contact | About | About
Symbol: CTXR
Recent Price: $3.91
Industry: Biotechnology
CEO: Mr. Leonard L. Mazur
Sector: Healthcare
Employees: 22
Address: 11 Commerce Drive, Cranford, NJ 07016
Phone: 908 967 6677
Leadership
- Leonard Mazur, Co-Founder, CEO & Chairman of the Board of Director
- Myron Holubiak, Co-Founder, Executive Vice Chairman
- Jaime Bartushak, Chief Financial Officer & Chief Business Officer
- Myron S. Czuczman, MD, Chief Medical Officer and EVP
- Gary F. Talarico, EVP, Operations
- Jay Wadekar, SVP, Business Strategy
- Kelly Creighton, PhD, EVP, Chemistry, Manufacturing and Controls
- Catherine Kessler, MS, EVP, Regulatory Affairs
- Nikolas Burlew, EVP, Quality Assurance
- Alan Lader, PhD, SVP, Head of Clinical Operations and Quality Assurance
- Ilanit Allen, VP, Investor Relations
- John Westman, VP, Project Management
- Paul Sowyrda, VP, Business Development & Market Intelligence
- Suren Dutia, Director
- Eugene Holuka, MD, Director
- Carol Webb, Director
- Dennis M. McGrath, Director
- Robert Smith, Director
Last updated: 2024-12-31
ORIC Pharmaceuticals, Inc.
ORIC-533, ORIC-944, ORIC-114
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.
Symbol: ORIC
Recent Price: $8.17
Industry: Biotechnology
CEO: Dr. Jacob M. Chacko M.B.A., M.D.
Sector: Healthcare
Employees: 107
Address: 240 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 388 5600
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Telomir Pharmaceuticals, Inc. Common Stock
TELOMIR-1
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.
Symbol: TELO
Recent Price: $4.64
Industry: Biotechnology
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 1
Address: 855 N Wolfe Street, Baltimore, null 21205
Phone: (737)-289-0835
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
Zentalis Pharmaceuticals, Inc.
ZN-c3, ZN-c5
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics for treating various cancers. Its leading product candidates include ZN-c3 and ZN-c5, which are in various phases of clinical trials targeting specific cancer types.
About | About | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: ZNTL
Recent Price: $2.92
Industry: Biotechnology
CEO: Dr. Kimberly Lynn Blackwell M.D.
Sector: Healthcare
Employees: 124
Address: 1359 Broadway, New York, NY 10018
Phone: 212 433 3791
Last updated: 2024-12-31
Belite Bio, Inc
LBS-008
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.
Symbol: BLTE
Recent Price: $61.97
Industry: Biotechnology
CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.
Sector: Healthcare
Employees: 20
Address: 5820 Oberlin Drive, San Diego, CA 92121
Phone: 858-246-6240
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
Mirum Pharmaceuticals, Inc.
LIVMARLI
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for rare and orphan diseases, with products like LIVMARLI and Volixibat.
Symbol: MIRM
Recent Price: $41.18
Industry: Biotechnology
CEO: Mr. Christopher Peetz
Sector: Healthcare
Employees: 294
Address: 950 Tower Lane, Foster City, CA 94404
Phone: 650 667 4085
Leadership
- Chris Peetz, Chief Executive Officer, Mirum Pharmaceuticals
- Erin Campany, Senior Vice President, Human Resources
- Eric Bjerkholt, Chief Financial Officer
- Jean-Luc Girardet, Ph.D., Senior Vice President, Technical Operations
- Vinita Kumar, Senior Vice President, Quality
- Lara Longpre, Chief Development Officer
- Joanne Quan, M.D., Chief Medical Officer
- Peter Radovich, President & Chief Operating Officer
- Paul Ross, Chief Compliance Officer
- Pamela Vig, Ph.D., Chief Scientific Officer and Head of Research
- Laura Brege, Board Member
- Patrick Heron, Managing General Partner, Frazier Healthcare Partners
- Tim Walbert, Former Chairman, President and Chief Executive Officer, Horizon Therapeutics; Sr. Advisor, Amgen
- Lon Cardon, Ph.D., FMedSci., Board Member
- William C. Fairey, Board Member
- Laurent Fischer, M.D., President & Chief Executive Officer, Adverum Biotechnologies
- Mike Grey, Chairman of the Board, Mirum Pharmaceuticals
- Saira Ramasastry, MS, MPhil, Managing Partner, Life Sciences Advisory, LLC
Last updated: 2024-12-31
Mineralys Therapeutics, Inc.
lorundrostat
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for hypertension and associated cardiovascular diseases, with its lead product candidate being lorundrostat.
Symbol: MLYS
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Jon Congleton
Sector: Healthcare
Employees: 28
Address: 150 N. Radnor Chester Rd., Radnor, PA 19087
Phone: 888-378-6240
Last updated: 2024-12-31
MediciNova, Inc.
MN-166 (ibudilast)
Medici Nova, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious diseases with unmet medical needs, including neurologic disorders, fibrotic diseases, and solid tumor cancers.
Symbol: MNOV
Recent Price: $2.11
Industry: Biotechnology
CEO: Dr. Yuichi Iwaki M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 4275 Executive Square, La Jolla, CA 92037
Phone: 858 373 1500
Leadership
- Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer, and Founder
- Kazuko Matsuda, M.D., Ph.D, MPH, Chief Medical Officer
- David H. Crean, Ph.D., Chief Business Officer
- Jason J. Kruger, CPA (inactive), Chief Financial Officer
- Hideki Nagao, Member of the Board of Directors
- Carolyn Beaver, Member of the Board of Directors
- Nicole Lemerond, CFA, Member of the Board of Directors
Last updated: 2024-12-31
Minerva Neurosciences, Inc.
Roluperidone
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for central nervous system diseases, including schizophrenia and Parkinson's disease.
Symbol: NERV
Recent Price: $2.29
Industry: Biotechnology
CEO: Dr. Remy Luthringer Ph.D.
Sector: Healthcare
Employees: 9
Address: 1601 Trapelo Road, Waltham, MA 02451
Phone: 617 600 7373
Leadership
- Remy Luthringer, PhD, Executive Chairman of the Board, Chief Executive Officer
- Geoff Race, FCMA, MBA, President
- Michael Davidson, M.D., Chief Medical Officer
- Frederick Ahlholm, CPA, Chief Financial Officer
- Joseph Reilly, Senior Vice President and Chief Operating Officer
- Jay Saoud, PhD, Consultant
- Hans Peter Hasler, Board Member
- Jan van Heek, Board Member
- David Kupfer, MD, Board Member
- Fouzia Laghrissi-Thode, MD, Board Member, Chief Executive Officer of DalCor Pharmaceuticals
Last updated: 2024-12-31
Phio Pharmaceuticals Corp.
INTASYL therapeutic platform
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics using its INTASYL therapeutic platform to target tumor and immune cells by regulating genes of the immune system, focusing on products like PH-762, PH-894, and PH-804 for enhancing cancer immunotherapies in adoptive cell transfer.
Symbol: PHIO
Recent Price: $1.90
Industry: Biotechnology
CEO: Mr. Robert J. Bitterman
Sector: Healthcare
Employees: 8
Address: 257 Simarano Drive, Marlborough, MA 01752
Phone: 508 767 3861
Last updated: 2024-12-31
Scilex Holding Company
ZTlido 1.8%
Scilex Holding Company is a biopharmaceutical company focused on developing and commercializing non-opioid management products for the treatment of acute and chronic pain, including its commercial product ZTlido 1.8% and several products in clinical trial stages.
About | About | About | News | News | Contact | Contact | Contact | About | About | About | About
Symbol: SCLX
Recent Price: $0.42
Industry: Drug Manufacturers - General
CEO: Mr. Jaisim Shah
Sector: Healthcare
Employees: 113
Address: 960 San Antonio Road, Palo Alto, CA 94303
Phone: 650-516-4310
Last updated: 2024-12-31
Vincerx Pharma, Inc.
VIP152
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company focused on researching and developing therapies to address unmet medical needs for cancer treatment in the United States. Their lead product candidate, VIP152, is a cyclin-dependent kinase-9 inhibitor for advanced cancer.
Symbol: VINC
Recent Price: $0.33
Industry: Biotechnology
CEO: Dr. Ahmed M. Hamdy M.D.
Sector: Healthcare
Employees: 42
Address: 260 Sheridan Avenue, Palo Alto, CA 94306
Phone: 650 800 6676
Last updated: 2024-12-31
Cencora
pharmaceutical products
Cencora, Inc. sources and distributes pharmaceutical products, offering a range of services including pharmacy management, supply management software, packaging solutions, and clinical trial support to various healthcare providers and manufacturers.
About | About | About | History | Leadership | Contact | Careers | Careers | Culture | Careers | DEI | Careers | Careers | Careers | DEI | Jobs | Jobs | Jobs | Jobs | Jobs | Management | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Management | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: COR
Recent Price: $224.71
Industry: Medical - Distribution
CEO: Dr. Robert P. Mauch Ph.D., PharmD
Sector: Healthcare
Employees: 46000
Address: 1 West First Avenue, Conshohocken, PA 19428
Phone: 610 727 7000
Last updated: 2024-12-31
Exelixis, Inc.
CABOMETYX, COMETRIQ, COTELLIC, MINNEBRO
Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines to treat cancers, primarily in the United States. Its products include CABOMETYX, COMETRIQ, COTELLIC, and MINNEBRO.
Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | Careers
Symbol: EXEL
Recent Price: $33.70
Industry: Biotechnology
CEO: Dr. Michael M. Morrissey Ph.D.
Sector: Healthcare
Employees: 1310
Address: 1851 Harbor Bay Parkway, Alameda, CA 94502
Phone: 650 837 7000
Last updated: 2024-12-31
Ionis Pharmaceuticals, Inc.
RNA-targeted therapeutics
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States, offering treatments like SPINRAZA, TEGSEDI, and WAYLIVRA, while developing medicines in phase 3 studies for various indications including TTR amyloidosis, severe hypertriglyceridemia, and amyotrophic lateral sclerosis.
About | About | About | DEI | DEI | DEI | DEI | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | About | About | News | About | About | ESG | DEI | DEI | About | About | About | Management | About | About | About | About | About | About | About | About | About | About | Careers | Careers | Careers | Careers | Careers | ESG | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About | About | About | Jobs | About | About
Symbol: IONS
Recent Price: $34.92
Industry: Biotechnology
CEO: Dr. Brett P. Monia Ph.D.
Sector: Healthcare
Employees: 927
Address: 2855 Gazelle Court, Carlsbad, CA 92010
Phone: 760 931 9200
Last updated: 2024-12-31
Nuvectis Pharma, Inc.
NXP800, NXP900
Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.
Symbol: NVCT
Recent Price: $5.14
Industry: Biotechnology
CEO: Mr. Ron Bentsur M.B.A.
Sector: Healthcare
Employees: 13
Address: 1 Bridge Plaza, Fort Lee, NJ 07024
Phone: 201 614 3150
Last updated: 2024-12-31